Showing results (151-160 of 276) with videos related to

Sort By:
Pageof 28
Journal of Surgical Oncology|March 9, 2026
Fertility-Sparing Surgery, Treatment Strategies and Survival of Women With Malignant Ovarian Germ Cell Tumours-A Descriptive Analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie CORSETT DatabaseMaximilian Klar, Malak Moubarak, Philipp Harter, et al.
International Journal of Surgery (London, England)|February 24, 2025
Risk factors for anastomotic leakage and its impact on survival outcomes in radical multivisceral surgery for advanced ovarian cancer: an AGO-OVAR.OP3/LION exploratory analysisFabian Trillsch, Bastian Czogalla, Sven Mahner, et al.
Annals of Surgical Oncology|March 16, 2021
Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 StudyLinn Woelber, Mareike Bommert, Philipp Harter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2010
Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: a randomized multicenter phase II trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study GroupJalid Sehouli, Dirk Stengel, Philipp Harter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2011
Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITOPhilipp Harter, Jalid Sehouli, Alexander Reuss, et al.
Gynecologic Oncology|November 10, 2020
Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?Nicolò Bizzarri, Andreas du Bois, Robert Fruscio, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2025
German S2k-guideline on diagnostics, treatment and surveillance of low-grade appendiceal mucinous neoplasms (LAMN)Franziska Köhler, Dirk Arnold, Daniela Aust, et al.
Gynecologic Oncology|February 15, 2019
Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 studyStephan Polterauer, Richard Schwameis, Christoph Grimm, et al.
Archives of Gynecology and Obstetrics|April 12, 2020
Prognostic role of thrombocytosis in recurrent ovarian cancer: a pooled analysis of the AGO Study GroupUlrich Canzler, Hans-Joachim Lück, Petra Neuser, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 28, 2023
Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR11/ICON-7Sabine Heublein, Jacobus Pfisterer, Andreas du Bois, et al.
Pageof 28